(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid (2S)-2-(4,6-二甲基嘧啶-2-基)氧基-3-甲氧基-3,3-二苯基丙酸
CAS 177036-94-1 MFCD08672619
化学结构图
SMILES: COC(C(OC1N=C(C)C=C(C)N=1)C(O)=O)(C1C=CC=CC=1)C1C=CC=CC=1
化学属性
| Mol. Formula | C22H22N2O4 |
|---|---|
| Mol. Weight | 378.426 |
别名和识别编码
| Chemical Name | (2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid |
|---|---|
| Chemical Name Translation | (2S)-2-(4,6-二甲基嘧啶-2-基)氧基-3-甲氧基-3,3-二苯基丙酸 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Lisk C, et al. Nrf2 activation: a potential strategy for the prevention of acute mountain sickness. Free Radic Biol Med. 2013 Oct;63:264-73.
- [1]. Okamoto T, et al. Antifibrotic effects of Ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model. World J Hepatol. 2016 Aug 8;8(22):933-41.
- [1]. Okamoto T, et al. Antifibrotic effects of Ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model. World J Hepatol. 2016 Aug 8;8(22):933-41.
- [2]. Lisk C, et al. Nrf2 activation: a potential strategy for the prevention of acute mountain sickness. Free Radic Biol Med. 2013 Oct;63:264-73.
